- Home
- LBTYK vs ZLAB Comparison
LBTYK vs ZLAB Comparison
Compare LBTYK & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBTYK
- ZLAB
- Stock Information
- Founded
- LBTYK 2004
- ZLAB 2013
- Country
- LBTYK Bermuda
- ZLAB China
- Employees
- LBTYK N/A
- ZLAB N/A
- Industry
- LBTYK Cable & Other Pay Television Services
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- LBTYK Telecommunications
- ZLAB Health Care
- Exchange
- LBTYK Nasdaq
- ZLAB Nasdaq
- Market Cap
- LBTYK 4.1B
- ZLAB 3.6B
- IPO Year
- LBTYK N/A
- ZLAB 2017
- Fundamental
- Price
- LBTYK $10.95
- ZLAB $32.42
- Analyst Decision
- LBTYK
- ZLAB Buy
- Analyst Count
- LBTYK 0
- ZLAB 6
- Target Price
- LBTYK N/A
- ZLAB $57.22
- AVG Volume (30 Days)
- LBTYK 922.6K
- ZLAB 524.9K
- Earning Date
- LBTYK 01-01-0001
- ZLAB 11-11-2025
- Dividend Yield
- LBTYK N/A
- ZLAB N/A
- EPS Growth
- LBTYK N/A
- ZLAB N/A
- EPS
- LBTYK N/A
- ZLAB N/A
- Revenue
- LBTYK $4,633,000,000.00
- ZLAB $427,799,000.00
- Revenue This Year
- LBTYK $12.99
- ZLAB $41.60
- Revenue Next Year
- LBTYK $1.75
- ZLAB $53.42
- P/E Ratio
- LBTYK N/A
- ZLAB N/A
- Revenue Growth
- LBTYK 81.79
- ZLAB 32.56
- 52 Week Low
- LBTYK $9.21
- ZLAB $23.82
- 52 Week High
- LBTYK $14.83
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- LBTYK 30.86
- ZLAB 47.44
- Support Level
- LBTYK $11.60
- ZLAB $32.87
- Resistance Level
- LBTYK $12.08
- ZLAB $33.97
- Average True Range (ATR)
- LBTYK 0.31
- ZLAB 0.92
- MACD
- LBTYK -0.11
- ZLAB 0.11
- Stochastic Oscillator
- LBTYK 1.72
- ZLAB 38.99
About LBTYK Liberty Global Ltd. Class C
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.